Linda Stein Gold, MD, discusses a new pooled post hoc analysis evaluating the efficacy and safety of tapinarof cream 1% in the treatment of atopic dermatitis, stratified by age and utilizing data from two identically designed, multicenter, randomized, phase 3 trials.
advertisement
Analyzing the Data on Tapinarof for Atopic Dermatitis
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Linda Stein Gold, MD, discusses a new pooled post hoc analysis evaluating the efficacy and safety of tapinarof cream 1% in the treatment of atopic dermatitis, stratified by age and utilizing data from two identically designed, multicenter, randomized, phase 3 trials.
Title
Program Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?